Join Us
Thursday, October 27, 2011
Ninth Annual Benefit Gala
Remember, Last Year's Event Sold Out
Testicular Cancer
Overall, approximately 96% of all testicular cancers are malignant. Testicular tumors are some of the fastest growing of all cancers and half of all men diagnosed already have evidence of metastases (spread to other areas of the body). This significantly complicates treatment options and compromises one's chances for survival.Testicular cancer affects primarily young, white males between the ages of 18 and 35. It is the most common form of cancer in men of this age group. However, it is a relatively rare disease. There are approximately 7,000 new cases diagnosed each year in the United States. For unknown reasons the incidence, or number of new cases per year, has doubled in the last two decades.
Although the overall cure rate is 94%, there are many patients with poor prognostic factors in whom 5-year survival rates are less than 40%. This year alone, approximately 400 American men will die from testicular cancer.
